Precision Medicine for Diabetic Retinopathy: Integrating Genetics, Biomarkers, Lifestyle, and AI
Genes · 16.09.2025 · 16 (9) · 1096
DOI: 10.3390/genes16091096 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 16.09.2025. Verfasst von Connor Kaurich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Precision Medicine, Artificial Intelligence. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NEI NIH HHS, National Institute of Health (NIH)—National Eye Institute (NEI).
Abstract (Originalsprache)
Diabetic retinopathy (DR) is a common sight-threatening complication of diabetes. Overall, 26% of the 37 million Americans with diabetes suffer from DR, and 5% of people with diabetes suffer from vision-threatening DR. DR is a heterogeneous disease; thus, it is essential to acknowledge this diversity as we advance toward precision medicine. The current classification for DR primarily focuses on the microvascular component of disease progression, which does not fully capture the heterogeneity of disease etiology in different patients. Further, researchers in the field have suggested renewed interest in improving diagnosis and treatment modalities for personalized care in DR management. Moreover, genetic factors, lifestyle, and environmental variation strongly affect the disease outcome. It is important to emphasize that various ocular and peripheral biomarkers, along with imaging techniques, significantly influence the diagnosis of DR. Therefore, in this review, we explore the heterogeneity of DR, genetic variations or polymorphism, lifestyle and environmental factors, and how these factors may affect the development of precision medicine for DR. First, we provide a rationale for the necessity of a multifaceted understanding of disease etiology. Next, we discuss different aspects of DR diagnosis, emphasizing the need for further stratification of patient populations to facilitate personalized treatment. We then discuss different genetics, race, sex, lifestyle, and environmental factors that could help personalize treatments for DR. Lastly, we summarize the available literature to elaborate how artificial intelligence can enhance diagnostics and disease classification and create personalized treatments, ultimately improving disease outcomes in DR patients who do not respond to first-line care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Connor Kaurich
Förderung
- NIDDK NIH HHS
- NEI NIH HHS
- National Institute of Health (NIH)—National Eye Institute (NEI)
Zitieren
APA
Kaurich, C., Mahajan, N., & Bhatwadekar, A. D. (2025). Precision Medicine for Diabetic Retinopathy: Integrating Genetics, Biomarkers, Lifestyle, and AI. Genes, 16(9), 1096. https://doi.org/10.3390/genes16091096
Vancouver
Kaurich C, Mahajan N, Bhatwadekar AD. Precision Medicine for Diabetic Retinopathy: Integrating Genetics, Biomarkers, Lifestyle, and AI. Genes. 2025;16(9):1096. doi:10.3390/genes16091096
BibTeX
@article{Kaurich2025,
author = {Kaurich, Connor and Mahajan, Neha and Bhatwadekar, Ashay D},
title = {Precision Medicine for Diabetic Retinopathy: Integrating Genetics, Biomarkers, Lifestyle, and AI},
journal = {Genes},
year = {2025},
volume = {16},
number = {9},
pages = {1096},
doi = {10.3390/genes16091096}
}
EUVIMED